VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HQY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HQYHealthEquity, Inc.
$101.84$8.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HQY logo

HealthEquity, Inc.

HQY
NASDAQ · Healthcare Software & Telehealth
$101.84
At close - Nov 17, 4:00 PM EST - USD
Market Cap$8.51B
P/E36.2x
52W High$110.26
Volume591.4K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2027Q2

Margin Expansion Offsets Decelerating Growth Trajectory

HealthEquity's investment case is anchored in its demonstrated ability to translate slowing revenue growth into robust profitability, with operating margins expanding from 15.2% in 2025Q1 to 28.1% in 2027Q2.

GrowthAccelerating
ProfitabilityStrong
ValuationExpensive
TechnicalsHealthy
Explore valuation models
MARKET ACTION

HQY price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

+65% Peers

P/E is 65% above peer median

03

Market leadership

RS 74 · Avg

Average momentum (RS Rating: 74)

04

Healthy Uptrend

Uptrend

Price > 50DMA > 200DMA

Next CatalystConfirmed earnings · Dec 1
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth has decelerated from a peak of 23.1% in 2025Q2 to 7.6% in 2027Q2, yet gross margins have expanded dramatically from 56.2% to 73.5% over the same period, indicating strong operating leverage on the technology platform.

Analyst Consensus+21.4% target
Buy(27 analysts)
25 Buy1 Hold1 Sell

The Bull Case

Upside Catalysts

Strong revenue and earnings growth

HealthEquity reported first-quarter revenue of US$354.64 million and net income of US$69.42 million, with a raised full-year fiscal 2027 earnings outlook.

Industry-leading HSA solutions

HealthEquity offers more than an industry-leading Health Savings Account (HSA), providing comprehensive benefits solutions for employers.

Positive analyst sentiment

Bullish theses from ValueInvestorsClub and Substack highlight optimism around HealthEquity's growth potential and market position.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
HQY+11.83%
S&P 500 (^GSPC)+7.21%
1-Year Return
HQY+1.67%
S&P 500 (^GSPC)+10.03%
3-Year Return
HQY+51.30%
S&P 500 (^GSPC)+59.91%
5-Year Return
HQY+55.96%
S&P 500 (^GSPC)+57.21%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
34.6x
Forward P/EExpansion
24.6x
EV/EBITDA20th %ile
17.4x
FCF YieldCash Flow
5.8%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
34.6x
101.3x
0th· Low
EV/EBITDA
17.4x
27.1x
20th· Low
Price/FCF
17.2x
33.4x
25th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$80.02-21.4%
Base (Fair)$128.18+23.9%
Bull$195.35+91.8%
$80.02 Bear$128.18 Base$195.35 Bull
Current Market Price: $101.84
Trades at a 20.5% discount to Base DCF ($128.18)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY26
$1.31B+9.5% YoY
Net income FY26
$215M+122.5% YoY
Free cash flow FY26
$455M+34.7% YoY
Operating margin FY26
24.6%+5.4 pts YoY
ROIC (FY26)8.5%
Avg ROIC 5Y4.2%
ROE (TTM)11.4%
Piotroski Score9 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate12/12 (100%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 27, 2026
$1.24+4.2%
vs $1.19
$351M+0.4%
vs $349M
Q2 2026
May 28, 2026
$1.24+11.7%
vs $1.11
$355M+0.7%
vs $352M
Q2 2026
Mar 17, 2026
$0.95+6.7%
vs $0.89
$335M+0.7%
vs $332M
Q4 2025
Dec 3, 2025
$1.01+10.7%
vs $0.91
$322M+0.5%
vs $321M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Zacks Investment Research·Nov 6, 2026
Reasons to Add HealthEquity Stock to Your Portfolio for Now

HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.

GlobeNewsWire·Nov 3, 2026
HealthEquity Schedules Third Quarter Earnings Release Date

DRAPER, Utah, Nov. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its third quarter of fiscal 2027, after the closing of regular stock market trading on Tuesday, December 1, 2026. Following the news release, HealthEquity management will host a conference call for investors on Tuesday, December 1, 2026, at 4:30 p.m. Eastern Time to review the Company's third quarter results.

Zacks Investment Research·Nov 3, 2026
BLCO vs. HQY: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Bausch + Lomb (BLCO) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?

Zacks Investment Research·Oct 28, 2026
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Filtered for HealthEquity, Inc.More Headlines
04

Compare before deciding

Benchmark HQY against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for HealthEquity, Inc. (HQY)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HQY logoHQYHealthEquity, Inc.Current
$101.84$8.51B36.189.47%17.36%11.43%—
WEX logoWEXWEX Inc.
$181.62$6.19B15.531.24%14.05%32.33%—
BEN logoBENFranklin Resources, Inc.
$34.41$17.88B15.197.43%12.38%8.15%3.93%
INVA logoINVAInnoviva, Inc.
$18.30$1.35B6.8218.52%43.79%15.84%—
GWRE logoGWREGuidewire Software, Inc.
$145.42$12.11B87.3022.7%9.44%10.03%—
PCTY logoPCTYPaylocity Holding Corporation
$177.50$9.5B34.1311.04%15.39%24.03%—

Compare HQY vs Peers

HealthEquity, Inc. (HQY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs WEX

Most directly comparable listed peer for HQY.

Scale Benchmark

vs UNH

Larger-name benchmark to compare HQY against a more recognizable public peer.

Peer Set

Compare Top 5

vs WEX, BEN, INVA, GWRE

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

HQY SEC Filings & Documents

HealthEquity, Inc. (HQY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 27, 2026·SEC

Material company update

May 28, 2026·SEC

Material company update

May 8, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 17, 2026·SEC

FY 2025

Mar 18, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 27, 2026·SEC

FY 2026

May 28, 2026·SEC

FY 2025

Dec 3, 2025·SEC

Get notified when HQY posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HQY Frequently Asked Questions

HealthEquity, Inc. (HQY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is HealthEquity, Inc.'s revenue?

HealthEquity, Inc. (HQY) reported $1.36B in revenue over the trailing twelve months. Revenue was $1.31B in fiscal year 2026. That is 2750% more than the $46.1M of fiscal year 2013.

How fast is HealthEquity, Inc. growing?

HealthEquity, Inc. (HQY) grew revenue by 7.3% over the trailing twelve months, compared with the twelve months before.

Is HQY profitable?

Yes. HealthEquity, Inc. (HQY) earned $236.5M in net income over the trailing twelve months (a 17.4% net margin).

Dividend & Returns
What is HQY's return on equity?

HealthEquity, Inc. (HQY) had a return on equity (ROE) of 11.4% over the trailing twelve months. That is in line with the market's typical 10-15%.

What is HealthEquity, Inc.'s free cash flow?

HealthEquity, Inc. (HQY) generated $471.7M in free cash flow over the trailing twelve months.

What if you invested $1,000 in HQY back in 2013?

Total return calculator · dividends reinvested · 13+ years of data

See returns →